 long-last depress factor xii-depend fibrinolyt system patient myocardi infarct thrombolyt therapi recombin tissue-typ plasminogen activ random placebo-control studi random placebo-control studi patient acut myocardi infarct intraven treatment mg recombin tissue-typ plasminogen activ rt-pa patient period treatment seven patient acut myocardi infarct streptokinas period treatment placebo group signific deviat endogen factor xii-depend fibrinolyt activ rt-pa group activ infus day signific decreas activ streptokinase-tr patient deplet factor xii-depend fibrinolyt activ due gener inhibit deplet factor xii prekallikrein plasminogen proactiv system rt-pa streptokinas treatment patient acut myocardi infarct prolong deplet factor xii-depend fibrinolyt activ depress endogen fibrinolyt activ relat risk coronari reocclus thrombolyt therapi